371 related articles for article (PubMed ID: 11083073)
1. Expression of a restrictive receptor for interleukin 13 is associated with glial transformation.
Debinski W; Slagle B; Gibo DM; Powers SK; Gillespie GY
J Neurooncol; 2000 Jun; 48(2):103-11. PubMed ID: 11083073
[TBL] [Abstract][Full Text] [Related]
2. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
[TBL] [Abstract][Full Text] [Related]
3. Receptor for interleukin 13 is abundantly and specifically over-expressed in patients with glioblastoma multiforme.
Debinski W; Gibo DM; Slagle B; Powers SK; Gillespie GY
Int J Oncol; 1999 Sep; 15(3):481-6. PubMed ID: 10427128
[TBL] [Abstract][Full Text] [Related]
4. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
[TBL] [Abstract][Full Text] [Related]
5. Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors.
Boado RJ; Black KL; Pardridge WM
Brain Res Mol Brain Res; 1994 Nov; 27(1):51-7. PubMed ID: 7877454
[TBL] [Abstract][Full Text] [Related]
6. Molecular expression analysis of restrictive receptor for interleukin 13, a brain tumor-associated cancer/testis antigen.
Debinski W; Gibo DM
Mol Med; 2000 May; 6(5):440-9. PubMed ID: 10952023
[TBL] [Abstract][Full Text] [Related]
7. Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumors.
Kawakami M; Kawakami K; Takahashi S; Abe M; Puri RK
Cancer; 2004 Sep; 101(5):1036-42. PubMed ID: 15329913
[TBL] [Abstract][Full Text] [Related]
8. Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas.
Debinski W; Gibo DM; Hulet SW; Connor JR; Gillespie GY
Clin Cancer Res; 1999 May; 5(5):985-90. PubMed ID: 10353730
[TBL] [Abstract][Full Text] [Related]
9. Expression of fibroblast growth factor receptor-1 in human glioma and meningioma tissues.
Ueba T; Takahashi JA; Fukumoto M; Ohta M; Ito N; Oda Y; Kikuchi H; Hatanaka M
Neurosurgery; 1994 Feb; 34(2):221-5; discussion 225-6. PubMed ID: 8177381
[TBL] [Abstract][Full Text] [Related]
10. Growth factor receptor expression varies among high-grade gliomas and normal brain: epidermal growth factor receptor has excellent properties for interstitial fusion protein therapy.
Liu TF; Tatter SB; Willingham MC; Yang M; Hu JJ; Frankel AE
Mol Cancer Ther; 2003 Aug; 2(8):783-7. PubMed ID: 12939468
[TBL] [Abstract][Full Text] [Related]
11. Analysis of isocitrate dehydrogenase 1 mutation in 97 patients with glioma.
Zhou YX; Wang JX; Feng M; Sun CM; Sun T; Chen GL; Du ZW
J Mol Neurosci; 2012 Jul; 47(3):442-7. PubMed ID: 22113362
[TBL] [Abstract][Full Text] [Related]
12. Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67.
Deckert M; Reifenberger G; Wechsler W
J Cancer Res Clin Oncol; 1989; 115(2):179-88. PubMed ID: 2715168
[TBL] [Abstract][Full Text] [Related]
13. C-erbB2/HER2 in human gliomas, medulloblastomas, and meningiomas: a minireview.
Waage IS; Vreim I; Torp SH
Int J Surg Pathol; 2013 Dec; 21(6):573-82. PubMed ID: 23842006
[TBL] [Abstract][Full Text] [Related]
14. Vimentin and glial fibrillary acidic protein in human brain tumors.
Yung WK; Luna M; Borit A
J Neurooncol; 1985; 3(1):35-8. PubMed ID: 3889231
[TBL] [Abstract][Full Text] [Related]
15. Nogo-A: a useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion.
Marucci G; Di Oto E; Farnedi A; Panzacchi R; Ligorio C; Foschini MP
Hum Pathol; 2012 Mar; 43(3):374-80. PubMed ID: 21835431
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of the estrogen receptor-related antigen (ER-D5) in human intracranial tumors.
Khalid H; Yasunaga A; Kishikawa M; Shibata S
Cancer; 1995 May; 75(10):2571-8. PubMed ID: 7736403
[TBL] [Abstract][Full Text] [Related]
17. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas.
Hau P; Kunz-Schughart LA; Rümmele P; Arslan F; Dörfelt A; Koch H; Lohmeier A; Hirschmann B; Müller A; Bogdahn U; Bosserhoff AK
J Neurooncol; 2006 Mar; 77(1):1-7. PubMed ID: 16292494
[TBL] [Abstract][Full Text] [Related]
18. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens.
Feldkamp MM; Lala P; Lau N; Roncari L; Guha A
Neurosurgery; 1999 Dec; 45(6):1442-53. PubMed ID: 10598712
[TBL] [Abstract][Full Text] [Related]
19. Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors.
Arnoldus EP; Wolters LB; Voormolen JH; van Duinen SG; Raap AK; van der Ploeg M; Peters AC
J Neurosurg; 1992 Jun; 76(6):997-1003. PubMed ID: 1588436
[TBL] [Abstract][Full Text] [Related]
20. EGFR immunolabeling pattern may discriminate low-grade gliomas from gliosis.
Burel-Vandenbos F; Benchetrit M; Miquel C; Fontaine D; Auvergne R; Lebrun-Frenay C; Cardot-Leccia N; Michiels JF; Paquis-Flucklinger V; Virolle T
J Neurooncol; 2011 Apr; 102(2):171-8. PubMed ID: 20652725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]